Cochrane · systematic review · CD010427
Antibiotic therapy for the treatment of methicillin‐resistant Staphylococcus aureus (MRSA) in non surgical wounds
Gurusamy, KS, Koti, R, Toon, CD, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
WoundsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Antibiotic therapy for treatment of MRSA in non surgical wounds
Population: patients with MRSA‐infected non surgical wounds
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Daptomycin versus vancomycin or semisynthetic penicillin | RR 1.13 [0.56, 2.25] | 1 study · 14 participants | Very low Downgraded: risk of bias |
Ertapenem versus piperacillin/tazobactam | RR 0.71 [0.06, 9.1] | 1 study · 10 participants | Very low Downgraded: risk of bias |
Moxifloxacin versus piperacillin/tazobactam followed by amoxycillin/clavulanate | RR 0.87 [0.56, 1.36] | 1 study · 23 participants | Very low Downgraded: risk of bias |